199 |
MEDISTRA "Excel" Drug Eluting Stent Trial (MEDISTRA): Medium-To-Long Term Outcome |
Teguh Santoso |
Jun. 09. 06 |
198 |
Jupiter I Beta and Jupiter II Meta-Analysis |
Thierry Lefevre |
Jun. 09. 06 |
197 |
The Xtent™ DES System: The Single Solution for Multilesion, Multivessel, and Long Lesion Treatment |
Eberhard Grube |
Jun. 09. 06 |
196 |
Carotid Stenting |
John R. Laird |
Jun. 02. 06 |
195 |
Biolimus A9 Drug-Eluting Stents: Technical Aspects and a Comprehensive Review of the EU, Asia-Pacific, and US NOBORI Clinical Trial Program |
Eberhard Grube |
Jun. 02. 06 |
194 |
Radiocontrast Nephropathy: Still the Achilles' Heel of Interventional Cardiology |
Roxana Mehran |
Jun. 02. 06 |
193 |
Virtual Histology of AMI |
Barry D. Rutherford |
Jun. 02. 06 |
192 |
DES Thrombosis: Is It Real and Is It Worse? New Approaches to Solving It ? |
David R. Holmes |
Jun. 02. 06 |
191 |
What Can 2D IVUS Teach Us About Vulnerable Plaque? |
Gary S. Mintz |
Jun. 02. 06 |
190 |
Metallic Biodegradeable Stent |
Ron Waksman |
May. 26. 06 |